{"product_id":"global-radiopharmaceuticals-market-growth-2023-2029","title":"Global Radiopharmaceuticals Market Growth 2023-2029","description":"\u003cp\u003eGlobal Radiopharmaceuticals Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eRadiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Radiopharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceuticals sales for 2023 through 2029. With Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceuticals industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radiopharmaceuticals market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceuticals.\u003cbr\u003e\nThe global Radiopharmaceuticals market size is projected to grow from US$ 6613.9 million in 2022 to US$ 11560 million in 2029; it is expected to grow at a CAGR of 11560 from 2023 to 2029.\u003cbr\u003e\nThe major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n Diagnostic Radioisotopes\u003cbr\u003e\n Therapeutic Radioisotopes\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Oncology\u003cbr\u003e\n Cardiology\u003cbr\u003e\n Other\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Bracco Imaging\u003cbr\u003e\n Bayer\u003cbr\u003e\n Mallinckrodt\u003cbr\u003e\n Nordion\u003cbr\u003e\n Triad Isotopes\u003cbr\u003e\n Lantheus\u003cbr\u003e\n IBA Group\u003cbr\u003e\n GE Healthcare\u003cbr\u003e\n China Isotope \u0026amp; Radiation\u003cbr\u003e\n Jubilant Pharma\u003cbr\u003e\n Eli Lilly\u003cbr\u003e\n Advanced Accelerator Applications\u003cbr\u003e\n SIEMENS\u003cbr\u003e\n Dongcheng\u003cbr\u003e\n Navidea\u003cbr\u003e\nKey Questions Addressed in this Report\u003cbr\u003e\nWhat is the 10-year outlook for the global Radiopharmaceuticals market?\u003cbr\u003e\nWhat factors are driving Radiopharmaceuticals market growth, globally and by region?\u003cbr\u003e\nWhich technologies are poised for the fastest growth by market and region?\u003cbr\u003e\nHow do Radiopharmaceuticals market opportunities vary by end market size?\u003cbr\u003e\nHow does Radiopharmaceuticals break out type, application?\u003cbr\u003e\nWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 119 Pages \/ MCW16234614","offer_id":47650982494514,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-radiopharmaceuticals-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}